rs145582574

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_173354.5(SIK1):​c.1072C>G​(p.Pro358Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0096 ( 14 hom., cov: 0)
Exomes 𝑓: 0.022 ( 488 hom. )
Failed GnomAD Quality Control

Consequence

SIK1
NM_173354.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.64

Publications

1 publications found
Variant links:
Genes affected
SIK1 (HGNC:11142): (salt inducible kinase 1) This gene encodes a serine/threonine protein kinase that contains a ubiquitin-associated (UBA) domain. The encoded protein is a member of the adenosine monophosphate-activated kinase (AMPK) subfamily of kinases that play a role in conserved signal transduction pathways. A mutation in this gene is associated with early infantile epileptic encephalopathy 30. [provided by RefSeq, Nov 2016]
SIK1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 30
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • early myoclonic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • generalized epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043595433).
BP6
Variant 21-43419906-G-C is Benign according to our data. Variant chr21-43419906-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 476075.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SIK1NM_173354.5 linkc.1072C>G p.Pro358Ala missense_variant Exon 9 of 14 ENST00000270162.8 NP_775490.2 P57059
SIK1XM_011529474.3 linkc.972+328C>G intron_variant Intron 8 of 12 XP_011527776.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SIK1ENST00000270162.8 linkc.1072C>G p.Pro358Ala missense_variant Exon 9 of 14 1 NM_173354.5 ENSP00000270162.6 P57059
SIK1ENST00000644871.1 linkn.17C>G non_coding_transcript_exon_variant Exon 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.00957
AC:
45
AN:
4704
Hom.:
14
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.000867
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00794
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0517
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0141
Gnomad OTH
AF:
0.0208
GnomAD2 exomes
AF:
0.00244
AC:
558
AN:
228454
AF XY:
0.00235
show subpopulations
Gnomad AFR exome
AF:
0.000436
Gnomad AMR exome
AF:
0.000367
Gnomad ASJ exome
AF:
0.00148
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00365
Gnomad NFE exome
AF:
0.00426
Gnomad OTH exome
AF:
0.00248
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0219
AC:
1178
AN:
53800
Hom.:
488
Cov.:
0
AF XY:
0.0224
AC XY:
630
AN XY:
28152
show subpopulations
African (AFR)
AF:
0.00532
AC:
7
AN:
1316
American (AMR)
AF:
0.00890
AC:
5
AN:
562
Ashkenazi Jewish (ASJ)
AF:
0.0140
AC:
25
AN:
1780
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3686
South Asian (SAS)
AF:
0.00279
AC:
11
AN:
3940
European-Finnish (FIN)
AF:
0.122
AC:
162
AN:
1332
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
262
European-Non Finnish (NFE)
AF:
0.0243
AC:
921
AN:
37906
Other (OTH)
AF:
0.0156
AC:
47
AN:
3016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00956
AC:
45
AN:
4706
Hom.:
14
Cov.:
0
AF XY:
0.0112
AC XY:
23
AN XY:
2060
show subpopulations
African (AFR)
AF:
0.000865
AC:
1
AN:
1156
American (AMR)
AF:
0.00
AC:
0
AN:
260
Ashkenazi Jewish (ASJ)
AF:
0.00794
AC:
2
AN:
252
East Asian (EAS)
AF:
0.00
AC:
0
AN:
96
South Asian (SAS)
AF:
0.00
AC:
0
AN:
112
European-Finnish (FIN)
AF:
0.0517
AC:
3
AN:
58
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
6
European-Non Finnish (NFE)
AF:
0.0141
AC:
38
AN:
2686
Other (OTH)
AF:
0.0208
AC:
1
AN:
48
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00287
Hom.:
8
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000913
AC:
4
ESP6500EA
AF:
0.00350
AC:
30
ExAC
AF:
0.00301
AC:
363

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Apr 26, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
May 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SIK1: BP4, BS2 -

Developmental and epileptic encephalopathy, 30 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
14
DANN
Benign
0.78
DEOGEN2
Benign
0.083
T
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.83
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.63
T
MetaRNN
Benign
0.0044
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
1.6
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.50
N
REVEL
Benign
0.076
Sift
Benign
0.26
T
Sift4G
Benign
0.74
T
Polyphen
0.0010
B
Vest4
0.17
MVP
0.32
MPC
0.18
ClinPred
0.0063
T
GERP RS
3.0
Varity_R
0.035
gMVP
0.15
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145582574; hg19: chr21-44839786; COSMIC: COSV54258051; COSMIC: COSV54258051; API